Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$7.85 - $8.94 $480,035 - $546,689
61,151 Added 3057550.0%
61,153 $509,000
Q2 2023

Aug 14, 2023

SELL
$8.04 - $9.0 $1.96 Million - $2.19 Million
-243,866 Reduced 100.0%
2 $0
Q1 2023

May 15, 2023

SELL
$7.57 - $8.37 $2.05 Million - $2.27 Million
-270,974 Reduced 52.63%
243,868 $1.99 Million
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $3.07 Million - $4.15 Million
514,842 New
514,842 $4.12 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.